Patents by Inventor Gerald Villeneuve

Gerald Villeneuve has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8557765
    Abstract: Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.
    Type: Grant
    Filed: May 26, 2009
    Date of Patent: October 15, 2013
    Assignee: Tranzyme Pharma Inc.
    Inventors: Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gérald Villeneuve, Mahesh Ramaseshan, Daniel Fortin, Mark L. Peterson, Hamid R. Hoveyda, Sylvie Beaubien, Éric Marsault, Graeme L. Fraser
  • Patent number: 8022252
    Abstract: Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.
    Type: Grant
    Filed: August 25, 2008
    Date of Patent: September 20, 2011
    Assignee: Tranzyme Pharma Inc.
    Inventors: Pierre Deslongchamps, Yves Dory, Kamel Benakli, Éric Marsault, Luc Ouellet, Mahesh Ramaseshan, Martin Vezina, Daniel Fortin, Ruoxi Lan, Shigui Li, Gérald Villeneuve, Hamid R. Hoveyda, Sylvie Beaubien, Mark L. Peterson
  • Patent number: 7772260
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: April 6, 2006
    Date of Patent: August 10, 2010
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley E. Hewitt, H. Nicholas Marsh
  • Patent number: 7741349
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: April 5, 2006
    Date of Patent: June 22, 2010
    Assignee: Aegera Therapeutics Inc.
    Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen J. Morris, Jon Durkin, John W. Gillard, Kimberley Hewitt, H. Nicholas Marsh
  • Publication number: 20090312540
    Abstract: Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target, in particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.
    Type: Application
    Filed: May 26, 2009
    Publication date: December 17, 2009
    Inventors: Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gerald Villeneuve, Mahesh Ramaseshan, Daniel Fortin, Mark L. Peterson, Hamid R. Hoveyda, Sylvie Beaubien, Eric Marsault, Graeme L. Fraser
  • Patent number: 7550431
    Abstract: Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.
    Type: Grant
    Filed: August 2, 2004
    Date of Patent: June 23, 2009
    Assignee: Tranzyme Pharma Inc.
    Inventors: Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gérald Villeneuve, Mahesh Ramaseshan, Daniel Fortin, Mark L. Peterson, Hamid R. Hoveyda, Sylvie Beaubien, Éric Marsault, Graeme L. Fraser
  • Publication number: 20090137817
    Abstract: Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.
    Type: Application
    Filed: August 25, 2008
    Publication date: May 28, 2009
    Inventors: Pierre Deslongchamps, Yves Dory, Kamel Benakli, Eric Marsault, Luc Ouellet, Mahesh Ramaseshan, Martin Vezina, Daniel Fortin, Ruoxi Lan, Shigui Li, Gerald Villeneuve, Hamid R. Hoveyda, Sylvie Beaubien, Mark L. Peterson
  • Publication number: 20090042953
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: April 7, 2008
    Publication date: February 12, 2009
    Applicant: AEGERA THERAPEUTICS, INC.
    Inventors: James B. JAQUITH, Gerald VILLENEUVE, Alain BOUDREAULT, Stephen J. MORRIS, Jon DURKIN, John W. GILLARD, Kimberley E. HEWITT, H. Nicholas MARSH
  • Patent number: 7452862
    Abstract: Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.
    Type: Grant
    Filed: August 2, 2004
    Date of Patent: November 18, 2008
    Assignee: Tranzyme Pharma, Inc.
    Inventors: Pierre Deslongchamps, Yves Dory, Mark Peterson, Kamel Benakli, Eric Marsault, Luc Ouellet, Mahesh Ramaseshan, Martin Vézina, Daniel Fortin, Ruoxi Lan, Shigui Li, Gérald Villeneuve, Hamid Hoveyda, Sylvie Beaubien, Graeme L Fraser
  • Patent number: 7230019
    Abstract: This invention relates to compounds of Formula (I) and the use of compounds of Formula (I) as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Grant
    Filed: December 16, 2002
    Date of Patent: June 12, 2007
    Assignee: Aegera Therapeutics, Inc.
    Inventors: James B. Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John W. Gillard, Kimberly Hewitt, H. Nicholas Marsh
  • Publication number: 20070088059
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: April 6, 2006
    Publication date: April 19, 2007
    Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt, H. Marsh
  • Publication number: 20070021416
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: April 6, 2006
    Publication date: January 25, 2007
    Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt, H. Marsh
  • Publication number: 20070021476
    Abstract: This invention relates to compounds of Formula I and the use of compounds of Formula I as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: April 5, 2006
    Publication date: January 25, 2007
    Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberley Hewitt, H. Marsh
  • Patent number: 7137175
    Abstract: A clipboard comprising a pair of clamping members arranged substantially parallel one above the other and connected to each other via an intermediate connecting member having a spring loaded hinge connection at each of its elongated ends for securely clamping articles, such as paper sheets, between one of the two clamping members and a board. The lower clamping member is used to hold an existing bundle of paper sheets on the board while disengaging the upper clamping member to add extra paper sheets to said existing bundle of paper sheets. The clamping members are positioned substantially parallel to each other and the lower clamping member extends through a slot formed at the center of a back portion of the first clamping member.
    Type: Grant
    Filed: October 12, 2001
    Date of Patent: November 21, 2006
    Inventor: Gerald Villeneuve
  • Publication number: 20050137127
    Abstract: Novel spatially-defined macrocyclic compounds containing specific conformational control elements are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.
    Type: Application
    Filed: August 2, 2004
    Publication date: June 23, 2005
    Applicant: TRANZYME PHARMA INC
    Inventors: Pierre Deslongchamps, Yves Dory, Mark Peterson, Kamel Benakli, Eric Marsault, Luc Ouellet, Mahesh Ramaseshan, Martin Vezina, Daniel Fortin, Ruoxi Lan, Shigui Li, Gerald Villeneuve, Hamid Hoveyda, Sylvie Beaubien
  • Publication number: 20050119169
    Abstract: Novel spatially-defined macrocyclic compounds incorporating peptide bond surrogates are disclosed. Libraries of these macrocycles are then used to select one or more macrocycle species that exhibit a specific interaction with a particular biological target. In particular, compounds according to the invention are disclosed as agonists or antagonists of a mammalian motilin receptor and a mammalian ghrelin receptor.
    Type: Application
    Filed: August 2, 2004
    Publication date: June 2, 2005
    Applicant: TRANZYME PHARMA INC.
    Inventors: Pierre Deslongchamps, Yves Dory, Luc Ouellet, Gerald Villeneuve, Mahesh Ramaseshan, Daniel Fortin, Mark Peterson, Hamid Hoveyda, Sylvie Beaubien, Eric Marsault
  • Publication number: 20050069492
    Abstract: This invention relates to compounds of Formula (I) and the use of compounds of Formula (I) as neuroprotective agents in the treatment of neuronal disorders of the central and peripheral nervous systems.
    Type: Application
    Filed: December 16, 2002
    Publication date: March 31, 2005
    Inventors: James Jaquith, Gerald Villeneuve, Alain Boudreault, Stephen Morris, Jon Durkin, John Gillard, Kimberly Hewitt, H. Marsh
  • Publication number: 20030070264
    Abstract: A clipboard comprising a pair of clamping members arranged substantially parallel one above the other and connected to each other via an intermediate connecting member having a spring loaded hinge connection at each of its elongated ends for securely clamping articles, such as paper sheets, between one of the two clamping members and a board. The lower clamping member is used to hold an existing bundle of paper sheets on the board while disengaging the upper clamping member to add extra paper sheets to said existing bundle of paper sheets. The clamping members are positioned substantially parallel to each other and the lower clamping member extends through a slot formed at the center of a back portion of the first clamping member.
    Type: Application
    Filed: October 12, 2001
    Publication date: April 17, 2003
    Inventor: Gerald Villeneuve
  • Patent number: 5758390
    Abstract: A cable tie which can be used for bundling electrical wires or many other objects. The cable tie of this invention comprises an elongate strap of plastic material composed of a longitudinal channel on one side and transversal notches on the other. This cable tie secures the wires by inserting its tail through either side of its block head. When the tail of the cable tie is inserted into the aperture located on a first side of the block head, the said cable tie becomes locked and impossible to be open (not re-usable). However, when the tail of the cable tie is inserted into the aperture located on the opposite side of the block head, the said cable tie becomes locked but re-usable by using a lever arm mechanism to release the elongate strap from the block head and open the cable tie.
    Type: Grant
    Filed: January 21, 1997
    Date of Patent: June 2, 1998
    Inventor: Gerald Villeneuve